| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |